Atrial fibrillation, or A-fib, is becoming more common, but doctors say treatments are improving. The condition is a ...

Abbott (NYSE: ABT) today announced new clinical data from two late-breaking presentations at AF Symposium in Boston (February 5-7, 2026) that demonstrate the strong safety and efficacy of the ...

Previously, patients with advanced atrial fibrillation (AF/AFib) had limited treatment choices. Since February 2024, West ...

Pulse Biosciences stock trading higher on promising clinical data for atrial fibrillation treatment, with potential for ...

Current Clinic launches specialized care model for AFib patients; completes inaugural cardiac ablation procedures in Carlsbad ambulatory surgery center CARLSBAD, N.M., Feb. 3, 2026 /PRNewswire/ -- ...

Abbott (NYSE: ABT) today announced new clinical data supporting its minimally invasive therapies for treating AFib.

Nurse practitioner Caitlin Massey from Ascension St. John Medical Center explains the symptoms, risks and new treatment options for atrial fibrillation, a common but serious heart rhythm disorder.

A new trial suggests Apple Watch could make a meaningful difference in what happens after atrial fibrillation ablation, not ...

The Apple Watch has plenty of potential for health monitoring even after discovery of a condition, and a new study outlines ...

In the U.S., the incidence of atrial fibrillation, the most common arrhythmia in the world, has more than doubled since 2010, increasing from 5 million to 10.5 million. Each year, 250,000 new cases ...

Doctors at Aspirus are recommending an alternative form of treatment called pulse field ablation (PFA). Dr. Ronnie Ortiz said the new treatment offers significant advantages over traditional methods.

Atrial fibrillation — the most common type of heart arrhythmia — affects roughly one in 22 Americans, disrupting the heart’s rhythm and increasing the risk of stroke and heart failure. While the ...